CopyPastehas never been so tasty!

Mycobacterium Infections Global Clinical Trials Review, H1

by anonymous

  • 0
  • 0
  • 0



“Mycobacterium Infections Global Clinical Trials Review, H1, 2013" provides data on the Mycobacterium Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mycobacterium Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mycobacterium Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Mycobacterium Infections 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Mycobacterium Infections 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Mycobacterium Infections Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Otsuka Pharmaceutical Co., Ltd. 37
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 37
Tibotec BVBA 38
Clinical Trial Overview of Tibotec BVBA 38
Abbott Laboratories 39
Clinical Trial Overview of Abbott Laboratories 39
Janssen Infectious Diseases 40
Clinical Trial Overview of Janssen Infectious Diseases 40
Johnson & Johnson 41
Clinical Trial Overview of Johnson & Johnson 41
Epicentre Biotechnologies 42
Clinical Trial Overview of Epicentre Biotechnologies 42
Cadila Pharmaceuticals Ltd. 4

For more information kindly visit :
Mycobacterium Infections Global Clinical Trials Review, H1, 2013


Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Follow us on twitter: 
Follow us on linkedin : 
Our Blog :

Add A Comment: